Hepion Pharmaceuticals, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−13.4046 USD
−13.19 M USD
0.00 USD
11.62 M
About Hepion Pharmaceuticals, Inc.
Sector
Industry
CEO
Kaouthar Lbiati
Website
Headquarters
Morristown
Founded
2013
IPO date
Feb 7, 2014
Identifiers
3
ISIN US4268972035
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hepion Pharmaceuticals, Inc. stocks are traded under the ticker CTRVP.
CTRVP reached its all-time high on Aug 14, 2025 with the price of 0.0013 USD, and its all-time low was 0.0013 USD and was reached on Aug 14, 2025. View more price dynamics on CTRVP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CTRVP stock is 0.00% volatile and has beta coefficient of 1.22. Track Hepion Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hepion Pharmaceuticals, Inc. there?
Today Hepion Pharmaceuticals, Inc. has the market capitalization of 697.22 K, it has increased by 13.07% over the last week.
Yes, you can track Hepion Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Hepion Pharmaceuticals, Inc. is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
CTRVP net income for the last quarter is −472.51 K USD, while the quarter before that showed −1.04 M USD of net income which accounts for 54.68% change. Track more Hepion Pharmaceuticals, Inc. financial stats to get the full picture.
No, CTRVP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CTRVP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hepion Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.